Journal of Diabetes Research

Journal of Diabetes Research / 2012 / Article
Special Issue

Noncoding RNAs

View this Special Issue

Erratum | Open Access

Volume 2012 |Article ID 672865 | https://doi.org/10.1155/2012/672865

Lotte B. Nielsen, Cheng Wang, Kaspar Sørensen, Claus H. Bang-Berthelsen, Lars Hansen, Marie-Louise M. Andersen, Philip Hougaard, Anders Juul, Chen-Yu Zhang, Flemming Pociot, Henrik B. Mortensen, "Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”", Journal of Diabetes Research, vol. 2012, Article ID 672865, 1 page, 2012. https://doi.org/10.1155/2012/672865

Erratum to “Circulating Levels of MicroRNA from Children with Newly Diagnosed Type 1 Diabetes and Healthy Controls: Evidence That miR-25 Associates to Residual Beta-Cell Function and Glycaemic Control during Disease Progression”

Received12 Sep 2012
Accepted20 Sep 2012
Published02 Dec 2012

The following sentence: Furthermore, miR-25 one month after diagnosis was positively associated with residual beta-cell function , and negatively associated with glycaemic control (HbA1c) 3 months after disease onset, should replace this sentence in the abstract of the existing paper: Furthermore, we identified miR-25 as negatively associated with residual beta-cell function (est.: −0.12, , and positively associated with glycaemic control (HbA1c) (est.: 0.11, 3 months after onset.

Copyright © 2012 Lotte B. Nielsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views702
Downloads381
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.